CFHR5
complement factor H related 5
Normal Function
Health Conditions Related to Genetic Changes
Atypical hemolytic-uremic syndrome
MedlinePlus Genetics provides information about Atypical hemolytic-uremic syndrome
More About This Health ConditionRelated Conditions
Atypical hemolytic-uremic syndromeC3 glomerulopathyAge-related macular degeneration
Health Conditions Related to Genetic Changes
MedlinePlus Genetics provides information about Atypical hemolytic-uremic syndrome
Several mutations in the CFHR5 gene have been found to cause a rare form of kidney disease called C3 glomerulopathy. This disorder damages the kidneys and can lead to end-stage renal disease (ESRD), a life-threatening condition that prevents the kidneys from filtering fluids and waste products from the body effectively.
The most common CFHR5 gene mutation has been identified in people from the Mediterranean island of Cyprus. This genetic change abnormally copies (duplicates) regions of the CFHR5 gene known as exons 2 and 3. The duplication alters the structure and function of complement factor H-related 5, preventing it from regulating the complement system effectively. As a result, the complement system becomes overactive, which damages structures called glomeruli in the kidneys. These structures are clusters of tiny blood vessels that help filter waste products from the blood. Damage to glomeruli prevents the kidneys from filtering waste products normally and can lead to ESRD.
Several other changes involving the CFHR5 gene do not cause C3 glomerulopathy directly but appear to increase the likelihood of developing the disorder. It is unclear how variations in this gene affect the regulation of the complement system, and researchers are still working to determine how these genetic changes contribute to disease risk.
MedlinePlus Genetics provides information about Age-related macular degeneration